| Dr Stacey Ellen Kostarides, PHARMD | |
|
20 Woodruff Ave, Narragansett, RI 02882-3423 | |
| (401) 792-7179 | |
| (401) 792-7184 |
| Full Name | Dr Stacey Ellen Kostarides |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 20 Woodruff Ave, Narragansett, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154557940 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH047037 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stacey Ellen Kostarides, PHARMD 20 Woodruff Ave, Narragansett, RI 02882-3423 Ph: (401) 792-7179 | Dr Stacey Ellen Kostarides, PHARMD 20 Woodruff Ave, Narragansett, RI 02882-3423 Ph: (401) 792-7179 |
News Archive
A new study, published today in the journal Scientific Reports, has identified a rural community in Brazil that still follows the earlier sleep and wake times similar to pre-industrial times.
Last week's report on Medicare projected that the program's hospital trust fund would be solvent until 2026 - two years longer than the last prediction. That slowing of health care costs, combined with shrinking near-term federal deficits and partisan gridlock are making a congressional deficit deal unlikely, at least until after the 2014 elections.
Registration for the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) - which will take place in Kuala Lumpur, Malaysia, from June 30 to July 3, 2013 - is now open through the conference webpage, which notes "[d]elegates are encouraged to register by 18 April 2013 ... to avoid the late fee surcharge, which begins on 19 April."
AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.
According to a new study published in The Lancet, a regular dose of aspirin may not only stave off heart disease but also cut the risk of developing hereditary cancer in half.
› Verified 7 days ago
Cynthia T Cruser, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 Woodruff Ave, Narragansett, RI 02882 Phone: 401-741-8415 | |
Christine Markut, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1123 Boston Neck Rd, Narragansett, RI 02882 Phone: 401-783-1753 | |
Casey Adams, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 91 Point Judith Rd, Narragansett, RI 02882 Phone: 401-783-7768 | |
Dr. Christine Barabas, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 Woodruff Ave, Rite Aid Pharmacy, Narragansett, RI 02882 Phone: 401-792-7179 | |
Cassandra Couture, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1123 Boston Neck Rd, Narragansett, RI 02882 Phone: 401-783-1753 | |
Linda Ann Carver, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 Woodruff Ave, Narragansett, RI 02882 Phone: 401-792-7179 Fax: 401-792-7184 |